End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
118,500 KRW | +0.42% | +6.37% | -5.58% |
05-20 | Gc Biopharma and Novel Pharma Announce Sanfilippo Syndrome Treatment Obtains FDA IND Approval | CI |
05-16 | GC Biopharma Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |